Acute Decompensated Heart Failure: Definition and Diagnosis
Acute decompensated heart failure (ADHF) is defined as the rapid onset or worsening of heart failure symptoms and signs—primarily dyspnea, pulmonary congestion, and peripheral edema—requiring urgent medical attention and treatment intensification. 1
Definition
ADHF represents a serious clinical syndrome characterized by:
- Rapid onset of symptoms and signs secondary to abnormal cardiac function 2, 3
- Systolic or diastolic myocardial dysfunction, valvular abnormalities, or cardiac rhythm disturbances 2
- Reduced cardiac output, decreased tissue perfusion, and increased pulmonary and/or peripheral congestion 2
- Can occur de novo (new onset) or as decompensation of known chronic heart failure 1
The most recent 2026 ESC guidelines emphasize that decompensated HF specifically requires severity sufficient to warrant urgent medical attention leading to unplanned hospital admission, emergency department visit, or ambulatory visit requiring treatment initiation or intensification 4.
Clinical Presentation
At presentation, expect the following symptom profile (based on the ADHERE registry data):
- 89% have dyspnea (shortness of breath on minimal effort or when lying down)
- 68% have pulmonary rales
- 66% have peripheral edema
- Only 2% present with systolic BP <90 mmHg 2
Additional common symptoms include cough, increasing abdominal girth, and fatigue 2.
Diagnostic Approach
Immediate Assessment (Within Minutes)
The 2016 ESC guidelines provide the most comprehensive diagnostic algorithm 1:
Natriuretic Peptides (Class I, Level A recommendation)
- Measure BNP, NT-proBNP, or MR-proANP in all patients with acute dyspnea
- Rule-out thresholds (low probability of ADHF):
- BNP <100 pg/mL
- NT-proBNP <300 pg/mL
- MR-proANP <120 pg/mL
- Rule-in thresholds (very high probability):
Critical caveat: In "flash" pulmonary edema, decompensated end-stage HF, or right-sided ADHF, BNP levels may be unexpectedly normal at initial presentation 1
12-Lead ECG (Class I, Level C)
Chest X-Ray (Class I, Level C)
Laboratory Tests at Admission (Class I, Level C)
Mandatory blood work 1:
- Cardiac troponin
- BUN (or urea) and creatinine
- Electrolytes (sodium, potassium)
- Glucose
- Complete blood count
- Liver function tests
- TSH (in newly diagnosed ADHF)
Echocardiography Timing
Immediate echocardiography is mandatory in 1:
- Hemodynamically unstable patients
- Suspected cardiogenic shock
- Suspected acute mechanical complications (valve rupture, ventricular septal defect, aortic dissection)
Within 48 hours when cardiac structure/function is unknown or may have changed since previous studies 1
Additional Diagnostic Considerations
Arterial blood gas analysis should be performed in patients with severe respiratory distress to assess oxygenation (pO2), respiratory function (pCO2), and acid-base balance 3. Acidosis indicates poor prognosis.
Physical examination priorities 3:
- Assess peripheral perfusion and skin temperature
- Evaluate jugular venous pressure (right heart filling pressures)
- Cardiac auscultation for S3/S4 gallops and murmurs (mitral regurgitation is extremely common)
- Pulmonary auscultation for bibasal rales
- Check for pleural effusions (common in chronic decompensated HF)
Clinical Phenotypes
The guidelines recognize distinct ADHF presentations requiring different management approaches 5:
- Acute decompensated congestive HF: Mild symptoms not meeting criteria for shock, pulmonary edema, or hypertensive crisis
- Hypertensive AHF: High BP with relatively preserved LV function and pulmonary edema
- Acute pulmonary edema: Severe respiratory distress, O2 saturation <90% on room air
- Cardiogenic shock: SBP <90 mmHg or MAP drop >30 mmHg, urine output <0.5 mL/kg/h
- High-output failure: High cardiac output with warm peripheries (thyrotoxicosis, anemia, sepsis)
- Right heart failure: Low output with elevated JVP, hepatomegaly, hypotension
The most recent 2016 ESC guidelines represent the highest quality evidence for diagnostic approach, superseding older classifications while maintaining their clinical utility 1.